Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2013

01.10.2013 | Breast Oncology

Novel Factors to Improve Prediction of Nodal Positivity in Patients with Clinical T1/T2 Breast Cancers

verfasst von: Tiffany Torstenson, DO, Miraj G. Shah-Khan, MD, Tanya L. Hoskin, MS, Marilyn J. Morton, DO, Darcy L. Adamczyk, MD, Katie N. Jones, MD, Jane Case, PA, Stephane Chartier, BS, Judy C. Boughey, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Memorial Sloan Kettering Cancer Center (MSKCC) and MD Anderson Cancer Center (MDACC) have established nomograms to predict sentinel node positivity. We propose the addition of two novel variables—distance of tumor from the nipple and from the skin—can improve their performance.

Methods

Ultrasounds of clinical T1/T2 tumors were reviewed. Distances of the tumor from the skin and from the nipple were measured. MSKCC and MDACC nomogram predictions and the AUC–ROC for each model were calculated. The added utility of the two variables was then examined using multiple logistic regression.

Results

Of 401 cancers studied, 79 (19.7 %) were node positive. The mean distance of tumors from the nipple in node-positive patients was 4.9 cm compared with 6.0 cm in node-negative patients (p = 0.0007). The mean distance of tumors from the skin was closer in node-positive cases (0.8 cm) versus node-negative cases (1.0 cm, p = 0.0007). The MSKCC and MDACC nomograms AUC–ROC values were 0.71 (95 % CI 0.64–0.77) and 0.74 (95 % CI 0.68–0.81). When adjusted for the MSKCC predicted probability, addition of both distance from nipple (p = 0.008) and distance from skin (p = 0.02) contributed significantly to prediction of nodal positivity and improved the AUC–ROC to 0.75 (95 % CI 0.70–0.81). Similarly, distance from nipple (p = 0.002), but not distance from skin (p = 0.09), added modestly to the MDACC nomogram performance (AUC 0.77; 95 % CI 0.71–0.83).

Conclusions

Distance of tumor from the nipple and from the skin are important variables associated with nodal positivity. Adding these to established nomograms improves prediction of nodal positivity.
Literatur
1.
Zurück zum Zitat Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103:492–500.PubMedCrossRef Viale G, Zurrida S, Maiorano E, Mazzarol G, Pruneri G, Paganelli G, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103:492–500.PubMedCrossRef
2.
Zurück zum Zitat Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman JP, et al. Identification of women with T1–T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65:34–9.PubMedCrossRef Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman JP, et al. Identification of women with T1–T2 breast cancer at low risk of positive axillary nodes. J Surg Oncol. 1997;65:34–9.PubMedCrossRef
3.
Zurück zum Zitat Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. Ann Surg Oncol. 2001;71:723–8. Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. Ann Surg Oncol. 2001;71:723–8.
4.
Zurück zum Zitat Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0–T1N1M0). Assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am. 1990;70:937–62.PubMed Rosen PP, Groshen S. Factors influencing survival and prognosis in early breast carcinoma (T1N0M0–T1N1M0). Assessment of 644 patients with median follow-up of 18 years. Surg Clin North Am. 1990;70:937–62.PubMed
5.
Zurück zum Zitat Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz PW, Leith AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32.PubMed Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz PW, Leith AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–32.PubMed
6.
Zurück zum Zitat Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.PubMedCrossRef Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.PubMedCrossRef
7.
Zurück zum Zitat Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, et al. Prerandomization Surgical Training for the NSABP-B32 trial—a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer. Ann Surg. 2005;241:48–54.PubMed Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, et al. Prerandomization Surgical Training for the NSABP-B32 trial—a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node negative breast cancer. Ann Surg. 2005;241:48–54.PubMed
8.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. New Eng J Med. 2003;349:546–53.PubMedCrossRef Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. New Eng J Med. 2003;349:546–53.PubMedCrossRef
9.
Zurück zum Zitat Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251:595–600.PubMedCrossRef Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251:595–600.PubMedCrossRef
10.
Zurück zum Zitat Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462–68.PubMedCrossRef Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462–68.PubMedCrossRef
13.
Zurück zum Zitat Bevilacqua JL, Kattan MW, Fey JV, Cody HS, 3rd, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 207;25:3670–9. Bevilacqua JL, Kattan MW, Fey JV, Cody HS, 3rd, Borgen PI, Van Zee KJ. Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation. J Clin Oncol. 207;25:3670–9.
14.
Zurück zum Zitat Veerapong J, Boughey JC, Mittendorf EA, Harrell R, Bassett R, Ross M, et al. A validated risk assessment of sentinel lymph node involvement in breast cancer patients. Ann Surg Oncol. 2011;18:S59 (Abstract) Veerapong J, Boughey JC, Mittendorf EA, Harrell R, Bassett R, Ross M, et al. A validated risk assessment of sentinel lymph node involvement in breast cancer patients. Ann Surg Oncol. 2011;18:S59 (Abstract)
15.
Zurück zum Zitat Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol. 2009;16:1136–42.PubMedCrossRef Klar M, Foeldi M, Markert S, Gitsch G, Stickeler E, Watermann D. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population. Ann Surg Oncol. 2009;16:1136–42.PubMedCrossRef
16.
Zurück zum Zitat Ansari B, Morton M, Adamczyk D, Jones KN, Brodt JK, Degnim AC, et al. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases. Ann Surg Oncol. 2011;18:3174–80.PubMedCrossRef Ansari B, Morton M, Adamczyk D, Jones KN, Brodt JK, Degnim AC, et al. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases. Ann Surg Oncol. 2011;18:3174–80.PubMedCrossRef
17.
Zurück zum Zitat Cunningham JE, Jurj AL, Oman L, Stonerock AE, Nitcheva DK, Cupples TE. Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin? Breast Cancer Res Treat. 2006;100:319–28.PubMedCrossRef Cunningham JE, Jurj AL, Oman L, Stonerock AE, Nitcheva DK, Cupples TE. Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin? Breast Cancer Res Treat. 2006;100:319–28.PubMedCrossRef
19.
Zurück zum Zitat Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg. 2009;229–35. doi:10.1016/j.jamcollsurg.2008.10.029. Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, et al. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg. 2009;229–35. doi:10.​1016/​j.​jamcollsurg.​2008.​10.​029.
20.
Zurück zum Zitat Cserni G. Comparison of different validation studies on the use of the Memorial Sloan-Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node-positive breast cancer patients. Am J Surg. 2007;194:699–700.PubMedCrossRef Cserni G. Comparison of different validation studies on the use of the Memorial Sloan-Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node-positive breast cancer patients. Am J Surg. 2007;194:699–700.PubMedCrossRef
21.
Zurück zum Zitat Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F, et al. Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol. 2009;27:2800–8.PubMedCrossRef Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchal F, Guillemin F, et al. Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol. 2009;27:2800–8.PubMedCrossRef
22.
Zurück zum Zitat Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190:543–50.PubMedCrossRef Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190:543–50.PubMedCrossRef
23.
Zurück zum Zitat Alran S, De Rycke Y, Fourchotte V, Charitansky H, Laki F, Falcou MC, Institute Curie Breast Cancer Study Group, et al.Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol. 2007;14:2195–201.PubMedCrossRef Alran S, De Rycke Y, Fourchotte V, Charitansky H, Laki F, Falcou MC, Institute Curie Breast Cancer Study Group, et al.Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol. 2007;14:2195–201.PubMedCrossRef
24.
Zurück zum Zitat Lieberman MA, Goldstein BA. Self-help online: an outcome evaluation of breast cancer bulletin boards. J Health Psychol. 2005;10:855–62.PubMedCrossRef Lieberman MA, Goldstein BA. Self-help online: an outcome evaluation of breast cancer bulletin boards. J Health Psychol. 2005;10:855–62.PubMedCrossRef
25.
Zurück zum Zitat Unruh HK, Bowen DJ, Meischke H, Bush N, Wooldridge JA. Women’s approach to the use of new technology for cancer risk information. Women Health. 2004;40:59–78.PubMedCrossRef Unruh HK, Bowen DJ, Meischke H, Bush N, Wooldridge JA. Women’s approach to the use of new technology for cancer risk information. Women Health. 2004;40:59–78.PubMedCrossRef
26.
Zurück zum Zitat Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, Pijpers R, van der Wall E, Licht J, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg. 2001;136:1059–63.PubMedCrossRef Rahusen FD, Torrenga H, van Diest PJ, Pijpers R, Pijpers R, van der Wall E, Licht J, et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg. 2001;136:1059–63.PubMedCrossRef
27.
Zurück zum Zitat Patani NR, Dwek MV, Douek M. Predictors of axillary lymph node metastasis in breast cancer: a systemic review. Eur J Surg Oncol. 2007;33:409–19.PubMedCrossRef Patani NR, Dwek MV, Douek M. Predictors of axillary lymph node metastasis in breast cancer: a systemic review. Eur J Surg Oncol. 2007;33:409–19.PubMedCrossRef
28.
Zurück zum Zitat Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–72.PubMedCrossRef Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767–72.PubMedCrossRef
29.
Zurück zum Zitat Cavalli LR. Molecular markers of breast axillary lymph node metastasis. Expert Rev Mol Diagn. 2009;9:441–54.PubMedCrossRef Cavalli LR. Molecular markers of breast axillary lymph node metastasis. Expert Rev Mol Diagn. 2009;9:441–54.PubMedCrossRef
30.
Zurück zum Zitat Cook, NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–35.PubMedCrossRef Cook, NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–35.PubMedCrossRef
31.
Zurück zum Zitat Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245:452–61.PubMedCrossRef Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245:452–61.PubMedCrossRef
Metadaten
Titel
Novel Factors to Improve Prediction of Nodal Positivity in Patients with Clinical T1/T2 Breast Cancers
verfasst von
Tiffany Torstenson, DO
Miraj G. Shah-Khan, MD
Tanya L. Hoskin, MS
Marilyn J. Morton, DO
Darcy L. Adamczyk, MD
Katie N. Jones, MD
Jane Case, PA
Stephane Chartier, BS
Judy C. Boughey, MD
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-013-3110-7

Weitere Artikel der Ausgabe 10/2013

Annals of Surgical Oncology 10/2013 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.